Advanced Imaging in Multiple Myeloma: New Frontiers for MRI

Plasma cell dyscrasias are estimated to newly affect almost 40,000 people in 2022. They fall on a spectrum of diseases ranging from relatively benign to malignant, the malignant end of the spectrum being multiple myeloma (MM). The International Myeloma Working Group (IMWG) has traditionally outlined...

Descripción completa

Detalles Bibliográficos
Autores principales: Torkian, Pooya, Azadbakht, Javid, Andrea Bonaffini, Pietro, Amini, Behrang, Chalian, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497462/
https://www.ncbi.nlm.nih.gov/pubmed/36140583
http://dx.doi.org/10.3390/diagnostics12092182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497462/
https://www.ncbi.nlm.nih.gov/pubmed/36140583
http://dx.doi.org/10.3390/diagnostics12092182

Ejemplares similares